Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report

Dopaminergic medication for motor symptoms in Parkinson’s disease recently has been linked with impulse control disorders, including pathological gambling, which affects up to 8% of patients. Pathological gambling often is considered a behavioral addiction associated with disinhibition, risky decisi...

Full description

Bibliographic Details
Main Authors: Mette Buhl Callesen, Kim Vang Hansen, Albert eGjedde, Jakob eLinnet, Arne eMøller
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-07-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00095/full
_version_ 1819117333123170304
author Mette Buhl Callesen
Mette Buhl Callesen
Kim Vang Hansen
Albert eGjedde
Albert eGjedde
Jakob eLinnet
Jakob eLinnet
Arne eMøller
Arne eMøller
author_facet Mette Buhl Callesen
Mette Buhl Callesen
Kim Vang Hansen
Albert eGjedde
Albert eGjedde
Jakob eLinnet
Jakob eLinnet
Arne eMøller
Arne eMøller
author_sort Mette Buhl Callesen
collection DOAJ
description Dopaminergic medication for motor symptoms in Parkinson’s disease recently has been linked with impulse control disorders, including pathological gambling, which affects up to 8% of patients. Pathological gambling often is considered a behavioral addiction associated with disinhibition, risky decision-making, and altered striatal dopaminergic neurotransmission. Using [11C]raclopride with positron emission tomography, we assessed dopaminergic neurotransmission during Iowa Gambling Task performance. Here we present data from a single patient with Parkinson’s disease and concomitant pathological gambling. We noted a marked decrease in [11C]raclopride binding in the left ventral striatum upon gambling, indicating a gambling-induced dopamine release. The results imply that pathological gambling in Parkinson’s disease is associated with a high dose of dopaminergic medication, pronounced motor symptomatology, young age at disease onset, high propensity for sensation seeking, and risky decision-making. Overall, the findings are consistent with the hypothesis of medication-related pathological gambling in Parkinson’s disease and underscore the importance of taking clinical variables, such as age and personality, into account when patients with Parkinson’s disease are medicated, to reduce the risk of pathological gambling.
first_indexed 2024-12-22T05:31:19Z
format Article
id doaj.art-0cce93ecb6b243249a9c52f511f3ef68
institution Directory Open Access Journal
issn 1662-5153
language English
last_indexed 2024-12-22T05:31:19Z
publishDate 2013-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Behavioral Neuroscience
spelling doaj.art-0cce93ecb6b243249a9c52f511f3ef682022-12-21T18:37:27ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532013-07-01710.3389/fnbeh.2013.0009558575Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case reportMette Buhl Callesen0Mette Buhl Callesen1Kim Vang Hansen2Albert eGjedde3Albert eGjedde4Jakob eLinnet5Jakob eLinnet6Arne eMøller7Arne eMøller8Aarhus University HospitalAarhus UniversityAarhus University HospitalAarhus University HospitalUniversity of CopenhagenAarhus UniversityAarhus UniversityAarhus University HospitalAarhus UniversityDopaminergic medication for motor symptoms in Parkinson’s disease recently has been linked with impulse control disorders, including pathological gambling, which affects up to 8% of patients. Pathological gambling often is considered a behavioral addiction associated with disinhibition, risky decision-making, and altered striatal dopaminergic neurotransmission. Using [11C]raclopride with positron emission tomography, we assessed dopaminergic neurotransmission during Iowa Gambling Task performance. Here we present data from a single patient with Parkinson’s disease and concomitant pathological gambling. We noted a marked decrease in [11C]raclopride binding in the left ventral striatum upon gambling, indicating a gambling-induced dopamine release. The results imply that pathological gambling in Parkinson’s disease is associated with a high dose of dopaminergic medication, pronounced motor symptomatology, young age at disease onset, high propensity for sensation seeking, and risky decision-making. Overall, the findings are consistent with the hypothesis of medication-related pathological gambling in Parkinson’s disease and underscore the importance of taking clinical variables, such as age and personality, into account when patients with Parkinson’s disease are medicated, to reduce the risk of pathological gambling.http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00095/fullDecision MakingDopamineImpulse Control DisordersParkinson DiseasePathological Gambling
spellingShingle Mette Buhl Callesen
Mette Buhl Callesen
Kim Vang Hansen
Albert eGjedde
Albert eGjedde
Jakob eLinnet
Jakob eLinnet
Arne eMøller
Arne eMøller
Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
Frontiers in Behavioral Neuroscience
Decision Making
Dopamine
Impulse Control Disorders
Parkinson Disease
Pathological Gambling
title Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
title_full Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
title_fullStr Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
title_full_unstemmed Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
title_short Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report
title_sort dopaminergic and clinical correlates of pathological gambling in parkinson 39 s disease a case report
topic Decision Making
Dopamine
Impulse Control Disorders
Parkinson Disease
Pathological Gambling
url http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00095/full
work_keys_str_mv AT mettebuhlcallesen dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT mettebuhlcallesen dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT kimvanghansen dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT albertegjedde dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT albertegjedde dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT jakobelinnet dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT jakobelinnet dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT arneemøller dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport
AT arneemøller dopaminergicandclinicalcorrelatesofpathologicalgamblinginparkinson39sdiseaseacasereport